• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序可识别侵袭性垂体腺瘤中的变异。

Whole-exome sequencing identifies variants in invasive pituitary adenomas.

作者信息

Lan Xiaolei, Gao Hua, Wang Fei, Feng Jie, Bai Jiwei, Zhao Peng, Cao Lei, Gui Songbai, Gong Lei, Zhang Yazhuo

机构信息

Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Department of Neurosurgery, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong 266071, P.R. China.

Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.

出版信息

Oncol Lett. 2016 Oct;12(4):2319-2328. doi: 10.3892/ol.2016.5029. Epub 2016 Aug 16.

DOI:10.3892/ol.2016.5029
PMID:27698795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5038494/
Abstract

Pituitary adenomas exhibit a wide range of behaviors. The prediction of invasion or malignant behavior in pituitary adenomas remains challenging. The objective of the present study was to identify the genetic abnormalities associated with invasion in sporadic pituitary adenomas. In the present study, the exomes of six invasive pituitary adenomas (IPA) and six non-invasive pituitary adenomas (nIPA) were sequenced by whole-exome sequencing. Variants were confirmed by dideoxynucleotide sequencing, and candidate driver genes were assessed in an additional 28 pituitary adenomas. A total of 15 identified variants were mainly associated with angiogenesis, metabolism, cell cycle phase, cellular component organization, cytoskeleton and biogenesis immune at a cellular level, including 13 variants that occurred as single nucleotide variants and 2 that comprised of insertions. The messenger RNA (mRNA) levels of diffuse panbronchiolitis critical region 1 (DPCR1), KIAA0226, myxovirus (influenza virus) resistance, proline-rich protein BstNI subfamily 3, PR domain containing 2, with ZNF domain, RIZ1 (PRDM2), PR domain containing 8 (PRDM8), SPANX family member N2 (SPANXN2), TRIO and F-actin binding protein and zinc finger protein 717 in IPA specimens were 50% decreased compared with nIPA specimens. In particular, DPCR1, PRDM2, PRDM8 and SPANXN2 mRNA levels in IPA specimens were approximately four-fold lower compared with nIPA specimens (P=0.003, 0.007, 0.009 and 0.004, respectively). By contrast, the mRNA levels of dentin sialophospho protein, EGF like domain, multiple 7 (EGFL7), low density lipoprotein receptor-related protein 1B and dynein, axonemal, assembly factor 1 (LRRC50) were increased in IPA compared with nIPA specimens (P=0.041, 0.037, 0.022 and 0.013, respectively). Furthermore, decreased PRDM2 expression was associated with tumor recurrence. The findings of the present study indicate that DPCR1, EGFL7, the PRDM family and LRRC50 in pituitary adenomas are modifiers of tumorigenesis, and most likely contribute to the development of oncocytic change and to the invasive tumor phenotype.

摘要

垂体腺瘤表现出广泛的行为特征。预测垂体腺瘤的侵袭性或恶性行为仍然具有挑战性。本研究的目的是确定散发性垂体腺瘤中与侵袭相关的基因异常。在本研究中,通过全外显子测序对6例侵袭性垂体腺瘤(IPA)和6例非侵袭性垂体腺瘤(nIPA)的外显子进行了测序。通过双脱氧核苷酸测序确认变异,并在另外28例垂体腺瘤中评估候选驱动基因。总共鉴定出15个变异,主要在细胞水平上与血管生成、代谢、细胞周期阶段、细胞成分组织、细胞骨架和生物合成免疫相关,其中包括13个单核苷酸变异和2个插入变异。与nIPA标本相比,IPA标本中弥漫性细支气管炎关键区域1(DPCR1)、KIAA0226、抗黏液病毒(流感病毒)、富含脯氨酸蛋白BstNI亚家族3、含PR结构域2(含ZNF结构域)、RIZ1(PRDM2)、含PR结构域8(PRDM8)、SPANX家族成员N2(SPANXN2)、TRIO和F-肌动蛋白结合蛋白以及锌指蛋白717的信使核糖核酸(mRNA)水平降低了50%。特别是,IPA标本中DPCR1、PRDM2、PRDM8和SPANXN2的mRNA水平比nIPA标本低约四倍(分别为P = 0.003、0.007、0.009和0.004)。相比之下,与nIPA标本相比,IPA中牙本质涎磷蛋白、EGF样结构域、多个7(EGFL7)、低密度脂蛋白受体相关蛋白1B和轴丝动力蛋白装配因子1(LRRC50)的mRNA水平升高(分别为P = 0.041、0.037、0.022和0.013)。此外,PRDM2表达降低与肿瘤复发相关。本研究结果表明,垂体腺瘤中的DPCR1、EGFL7、PRDM家族和LRRC50是肿瘤发生的调节因子,很可能促进嗜酸性细胞变化的发展和侵袭性肿瘤表型的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/ef4778c539a8/ol-12-04-2319-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/2ebea5091b47/ol-12-04-2319-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/9346c566754e/ol-12-04-2319-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/ef4778c539a8/ol-12-04-2319-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/2ebea5091b47/ol-12-04-2319-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/9346c566754e/ol-12-04-2319-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a450/5038494/ef4778c539a8/ol-12-04-2319-g02.jpg

相似文献

1
Whole-exome sequencing identifies variants in invasive pituitary adenomas.全外显子组测序可识别侵袭性垂体腺瘤中的变异。
Oncol Lett. 2016 Oct;12(4):2319-2328. doi: 10.3892/ol.2016.5029. Epub 2016 Aug 16.
2
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.PRDM2表达降低与催乳素瘤中的多巴胺激动剂抵抗及肿瘤复发相关。
BMC Cancer. 2015 Apr 12;15:272. doi: 10.1186/s12885-015-1267-0.
3
Whole-exome sequencing studies of nonfunctioning pituitary adenomas.非功能性垂体腺瘤的全外显子组测序研究。
J Clin Endocrinol Metab. 2013 Apr;98(4):E796-800. doi: 10.1210/jc.2012-4028. Epub 2013 Feb 28.
4
The role of FSCN1 in migration and invasion of pituitary adenomas.FSCN1在垂体腺瘤迁移和侵袭中的作用。
Mol Cell Endocrinol. 2016 Jan 5;419:217-24. doi: 10.1016/j.mce.2015.10.021. Epub 2015 Oct 29.
5
Study on the expression levels of CXCR4, CXCL12, CD44, and CD147 and their potential correlation with invasive behaviors of pituitary adenomas.研究 CXCR4、CXCL12、CD44 和 CD147 的表达水平及其与垂体腺瘤侵袭行为的潜在相关性。
Biomed Environ Sci. 2013 Jul;26(7):592-8. doi: 10.3967/0895-3988.2013.07.011.
6
Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas.促甲状腺素分泌型垂体腺瘤的全外显子组测序研究
J Clin Endocrinol Metab. 2017 Feb 1;102(2):566-575. doi: 10.1210/jc.2016-2261.
7
[The Role of Cancer-associated Fibroblasts in Invasive Behavior of Pituitary Adenoma].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;46(5):673-8.
8
The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc.PRDM2 的缺失通过调节 c-Myc 参与了生长激素腺瘤的发生。
Gene. 2020 May 5;737:144456. doi: 10.1016/j.gene.2020.144456. Epub 2020 Feb 7.
9
EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.表皮生长因子样蛋白7通过Notch2/DLL3信号通路参与调控生长激素分泌型垂体腺瘤的生物学行为。
Tumour Biol. 2017 Jul;39(7):1010428317706203. doi: 10.1177/1010428317706203.
10
RIZ1 and histone methylation status in pituitary adenomas.垂体腺瘤中的RIZ1与组蛋白甲基化状态
Tumour Biol. 2017 Jul;39(7):1010428317711794. doi: 10.1177/1010428317711794.

引用本文的文献

1
Genetic profiling of synchronous pituitary corticotroph adenomas.同步垂体促肾上腺皮质激素腺瘤的基因谱分析
Pituitary. 2025 Jun 22;28(4):77. doi: 10.1007/s11102-025-01549-6.
2
A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma.一种解整合素金属蛋白酶 22 通过其解整合素结构域激活整合素 β1,从而促进垂体腺瘤的进展。
Neuro Oncol. 2024 Jan 5;26(1):137-152. doi: 10.1093/neuonc/noad148.
3
Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours.

本文引用的文献

1
Pathogenesis analysis of pituitary adenoma based on gene expression profiling.基于基因表达谱的垂体腺瘤发病机制分析
Oncol Lett. 2014 Dec;8(6):2423-2430. doi: 10.3892/ol.2014.2613. Epub 2014 Oct 13.
2
GH3 tumor pituitary cell cytoskeleton and plasma membrane arrangement are determined by extracellular matrix proteins: implications on motility, proliferation and hormone secretion.生长激素3型垂体肿瘤细胞的细胞骨架和质膜排列由细胞外基质蛋白决定:对细胞运动、增殖和激素分泌的影响
Int J Physiol Pathophysiol Pharmacol. 2014 Jul 12;6(2):66-83. eCollection 2014.
3
Aggressive pituitary adenomas--diagnosis and emerging treatments.
β-连环蛋白丝氨酸 552 磷酸化与无功能垂体神经内分泌肿瘤的侵袭和复发相关。
Acta Neuropathol Commun. 2022 Sep 16;10(1):138. doi: 10.1186/s40478-022-01441-5.
4
Alterations of the Gut Microbiome in Patients With Pituitary Adenoma.垂体腺瘤患者肠道微生物组的改变。
Pathol Oncol Res. 2022 Aug 4;28:1610402. doi: 10.3389/pore.2022.1610402. eCollection 2022.
5
Aggressive pituitary tumours and pituitary carcinomas.侵袭性垂体肿瘤和垂体癌。
Nat Rev Endocrinol. 2021 Nov;17(11):671-684. doi: 10.1038/s41574-021-00550-w. Epub 2021 Sep 7.
6
Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives.垂体神经内分泌肿瘤的大规模分子研究:新标志物、机制及转化前景
Cancers (Basel). 2021 Mar 19;13(6):1395. doi: 10.3390/cancers13061395.
7
Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.外泌体中MiR-149-5p和MiR-99a-3p表达上调可抑制垂体腺瘤进展。
Cell Biol Toxicol. 2021 Aug;37(4):633-651. doi: 10.1007/s10565-020-09570-0. Epub 2021 Jan 5.
8
Multifaceted Role of PRDM Proteins in Human Cancer.PRDM 蛋白在人类癌症中的多方面作用。
Int J Mol Sci. 2020 Apr 10;21(7):2648. doi: 10.3390/ijms21072648.
9
Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.垂体肿瘤发生的新见解:遗传和表观遗传机制。
Endocr Rev. 2020 Dec 1;41(6):821-46. doi: 10.1210/endrev/bnaa006.
10
Association of NM23 polymorphisms and clinicopathological features and recurrence of invasive pituitary adenomas.NM23 多态性与侵袭性垂体腺瘤的临床病理特征及复发的关系。
Pituitary. 2020 Apr;23(2):113-119. doi: 10.1007/s11102-019-01006-1.
侵袭性垂体腺瘤——诊断和新兴治疗方法。
Nat Rev Endocrinol. 2014 Jul;10(7):423-35. doi: 10.1038/nrendo.2014.64. Epub 2014 May 13.
4
Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis.表皮生长因子样结构域7是内皮细胞谱系和活跃血管生成的标志物。
Genesis. 2014 Jul;52(7):657-70. doi: 10.1002/dvg.22781. Epub 2014 May 2.
5
Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.侵袭性相对于非侵袭性无功能垂体腺瘤的蛋白质组学差异鉴定。
Electrophoresis. 2014 Aug;35(15):2184-94. doi: 10.1002/elps.201300590.
6
Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China.MHC区域的变异使中国北方高发地区的受试者患食管鳞状细胞癌的风险增加。
PLoS One. 2014 Mar 4;9(3):e90438. doi: 10.1371/journal.pone.0090438. eCollection 2014.
7
Clinical aggression of prolactinomas: correlations with invasion and recurrence.催乳素瘤的临床侵袭性:与侵袭及复发的相关性
Rom J Morphol Embryol. 2013;54(4):1075-80.
8
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients.肺癌患者单个循环肿瘤细胞中的可重现拷贝数变异模式。
Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21083-8. doi: 10.1073/pnas.1320659110. Epub 2013 Dec 9.
9
Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.PRB3 mRNA 水平低与催乳素瘤中多巴胺激动剂抵抗和肿瘤复发有关。
J Neurooncol. 2014 Jan;116(1):83-8. doi: 10.1007/s11060-013-1276-2. Epub 2013 Oct 18.
10
Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.脑垂体腺瘤中半乳糖凝集素-3 的表达作为侵袭性行为的标志物。
Hum Pathol. 2013 Nov;44(11):2400-9. doi: 10.1016/j.humpath.2013.05.020. Epub 2013 Sep 2.